Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection
- PMID: 32271254
- DOI: 10.1097/QAD.0000000000002480
Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection
Comment in
-
Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.AIDS. 2020 May 1;34(6):955-956. doi: 10.1097/QAD.0000000000002481. AIDS. 2020. PMID: 32271255 No abstract available.
Comment on
-
Cannabinoids and inflammation: implications for people living with HIV.AIDS. 2019 Dec 1;33(15):2273-2288. doi: 10.1097/QAD.0000000000002345. AIDS. 2019. PMID: 31764093 Review.
References
-
- Costiniuk CT, Jenabian M-A. Cannabinoids and inflammation: implications for people living with HIV. AIDS 2019; 33:2273–2288.
-
- Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, et al. HEPAVIH ANRS CO13 Study GroupNo significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev 2016; 36:227–238.
-
- Brunet L, Moodie EEM, Rollet K, Cooper C, Walmsley S, Potter M, et al. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: A longitudinal Cohort analysis. Clin Infect Dis 2013; 57:663–670.
-
- Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, et al. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women. Clin Infect Dis 2016; 63:512–518.
-
- Marcellin F, Protopopescu C, Wittkop L, Salmon-Ceron D, Sogni P, Carrieri MP, et al. ANRS CO13 HEPAVIH Study GroupNo influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study). Eur J Gastroenterol Hepatol 2019; 31:274–276.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
